(Q40618283)

22 September 2017

title

Two novel fully functional isoforms of CX3CR1 are potent HIV coreceptors (English)

1 reference

22 September 2017

Two Novel Fully Functional Isoforms of CX3CR1 Are Potent HIV Coreceptors (English)

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

30 March 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

30 March 2024

author name string

Alexandre Garin

1

1 reference

22 September 2017

Nadine Tarantino

2

1 reference

22 September 2017

Sophie Faure

3

1 reference

22 September 2017

Mehdi Daoudi

4

1 reference

22 September 2017

Cédric Lécureuil

5

1 reference

22 September 2017

Anne Bourdais

6

1 reference

22 September 2017

Patrice Debré

7

1 reference

22 September 2017

Philippe Deterre

8

1 reference

22 September 2017

Christophe Combadiere

9

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

22 September 2017

15 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14607932

full work available at URL

30 March 2024

published in

Journal of Immunology

1 reference

22 September 2017

volume

171

1 reference

22 September 2017

issue

10

1 reference

22 September 2017

page(s)

5305-5312

1 reference

The molecular biology of leukocyte chemoattractant receptors

22 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

Chemokines--chemotactic cytokines that mediate inflammation

30 March 2024

2

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

Chemokines in pathology and medicine

30 March 2024

3

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1alpha receptor, confers chemokine selectivity. Evidence for a two-step mechanism for MCP-1 receptor activation

30 March 2024

6

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

The N-terminal extracellular segments of the chemokine receptors CCR1 and CCR3 are determinants for MIP-1alpha and eotaxin binding, respectively, but a second domain is essential for efficient receptor activation

30 March 2024

7

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

30 March 2024

8

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding

30 March 2024

9

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5

30 March 2024

10

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

Chemokine receptors and chemokines in HIV infection

30 March 2024

11

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

30 March 2024

13

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

The role of CCR5 chemokine ligands and antibodies to CCR5 coreceptors in preventing HIV infection

30 March 2024

14

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines

30 March 2024

15

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity

30 March 2024

16

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

CCR9A and CCR9B: two receptors for the chemokine CCL25/TECK/Ck beta-15 that differ in their sensitivities to ligand

30 March 2024

17

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails

30 March 2024

19

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1

30 March 2024

20

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease

30 March 2024

21

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

A new class of membrane-bound chemokine with a CX3C motif

30 March 2024

22

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion

30 March 2024

23

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression

30 March 2024

24

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia?

30 March 2024

25

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival

30 March 2024

26

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia

30 March 2024

27

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo

30 March 2024

28

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation

30 March 2024

29

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow

30 March 2024

30

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury

30 March 2024

31

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection

30 March 2024

32

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice.

30 March 2024

33

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis

30 March 2024

34

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

CD4-independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry

30 March 2024

36

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1

30 March 2024

37

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

Genetic Polymorphism in CX3CR1 and Risk of HIV Disease

30 March 2024

38

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

Improved resolution of myofibrillar proteins with sodium dodecyl sulfate-polyacrylamide gel electrophoresis

30 March 2024

40

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

Cloning and functional characterization of the human fractalkine receptor promoter regions

30 March 2024

43

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by the nucleotides in positions +5 and +6.

30 March 2024

44

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

Sialylated O-glycans and sulfated tyrosines in the NH2-terminal domain of CC chemokine receptor 5 contribute to high affinity binding of chemokines

30 March 2024

45

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

Interpreting cDNA sequences: some insights from studies on translation

30 March 2024

46

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

CX3CR1 tyrosine sulfation enhances fractalkine-induced cell adhesion

30 March 2024

47

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

Coreceptors--Implications for HIV Pathogenesis and Therapy

30 March 2024

48

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry

30 March 2024

49

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5305

30 March 2024

Identifiers

1 reference

22 September 2017

1 reference